KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Other Accumulated Expenses (2018 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Other Accumulated Expenses for 8 consecutive years, with $826000.0 as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses changed 0.48% to $826000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $826000.0 through Dec 2025, changed 0.48% year-over-year, with the annual reading at $826000.0 for FY2025, 0.48% changed from the prior year.
  • Other Accumulated Expenses hit $826000.0 in Q4 2025 for Adaptive Biotechnologies, roughly flat from $830000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $1.7 million in Q4 2022 to a low of $763000.0 in Q4 2023.
  • Historically, Other Accumulated Expenses has averaged $1.0 million across 5 years, with a median of $830000.0 in 2024.
  • Biggest five-year swings in Other Accumulated Expenses: surged 58.52% in 2022 and later tumbled 53.9% in 2023.
  • Year by year, Other Accumulated Expenses stood at $1.0 million in 2021, then soared by 58.52% to $1.7 million in 2022, then crashed by 53.9% to $763000.0 in 2023, then grew by 8.78% to $830000.0 in 2024, then fell by 0.48% to $826000.0 in 2025.
  • Business Quant data shows Other Accumulated Expenses for ADPT at $826000.0 in Q4 2025, $830000.0 in Q4 2024, and $763000.0 in Q4 2023.